Medicine Description forteo 750 mcg
Forteo750 microgram pen is a medication that contains teriparatide, a synthetic form of parathyroid hormone. It functions by stimulating osteoblast activity, which leads to increased bone formation. Teriparatide promotes the proliferation and activity of bone-forming cells (osteoblasts), enhancing new bone tissue formation while simultaneously inhibiting apoptosis (cell death) of these cells. This dual action not only builds new bone but also improves bone mineral density, thus reducing the risk of fractures in patients with osteoporosis. Teriparatide also has effects on calcium metabolism, leading to enhanced intestinal absorption of calcium and decreased renal excretion, contributing to overall skeletal health.
Indications and Uses of Forteo750 microgram pen
- Osteoporosis in postmenopausal women
- Osteoporosis in men
- Osteoporosis induced by long-term glucocorticoid therapy
Side Effects of Forteo750 microgram pen
- Nausea
- Dizziness
- Leg cramps
- Joint pain
- Injection site reactions
- Hypercalcemia
Storage and Handling
Store Forteo750 microgram pen in a refrigerator between 2°C and 8°C (36°F and 46°F). Do not freeze. Once in use, it can be kept at room temperature, away from direct sunlight, for a maximum of 28 days.
Patient Advice and Precautions
Patients should be counseled to rotate injection sites to minimize discomfort and to ensure proper disposal of used pens. It is important to monitor calcium levels periodically due to the risk of hypercalcemia. Patients with a history of bone metastases, skeletal malignancies, or other specific conditions should consult their healthcare provider before starting treatment with Forteo.